Searched for
TORRENT PHARMACEUTICALS INDIA REVENUE
Torrent Pharmaceuticals Q1 Results: Profit rises 3% to Rs 566 croreTorrent Pharmaceuticals announced a robust profit after tax of Rs 566 crore for the first quarter, showcasing impressive growth. Revenue so...- ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
- Kazakhstan eyes stronger trade ties with West BengalKazakhstan's ambassador expressed keen interest in expanding business engagement with West Bengal. The nation views West Bengal as a crucia...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- Cipla expects sequential recovery in North America on new product launches despite tariff uncertaintyCipla reported a 39% drop in net profit to ₹789 crore for the June quarter due to weakness in its North America business and margin compres...
- Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investorsIndian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact ...
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Axis Bank among 5 F&O stocks with a sharp rise in futures open interestFive NSE F&O stocks, including Radico Khaitan, Torrent Pharma and Axis Bank, recorded over 6% growth in futures open interest, indicating f...
- Union Bank of India among 7 stocks flashing bullish signals, hinting at a possible uptrendOn July 20, seven stocks in the Nifty500 appeared on the 'White Marubozu' bullish scanner, according to StockEdge's technical scan data. Th...
- Positive Breakout: These 13 stocks cross above their 200 DMAsAs long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend. Take a...
- Tata Elxsi among 4 F&O stocks with a sharp rise in futures open interestNine NSE F&O stocks witnessed over 10% rise in futures open interest on July 15, indicating increased market participation, fresh positions...
Load More
